|
MICROSEMI CORPORATION Summary of Schedule Reconciling Selected Non-GAAP Financial Measures to Comparable GAAP Financial Measures Quarter Ended September 30, 2012 (Unaudited, in millions except for per share amounts) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP |
Non-GAAP Adjustments |
Non-GAAP | ||||||
|
Net sales |
|
$ |
263.1 |
|
$ |
— |
|
$ |
263.1 |
|
|
Gross profit |
|
$ |
150.4 |
|
$ |
— |
|
$ |
150.4 |
|
|
Operating expense |
|
$ |
123.8 |
|
$ |
(37.9) |
|
$ |
85.9 |
|
|
Operating income |
|
$ |
26.6 |
|
$ |
37.9 |
|
$ |
64.5 |
|
|
Interest and other expense, net |
|
$ |
(8.6) |
|
$ |
0.1 |
|
$ |
(8.5) |
|
|
Income before income taxes |
|
$ |
18.0 |
|
$ |
38.0 |
|
$ |
56.0 |
|
|
Provision for income taxes |
|
$ |
6.4 |
|
$ |
(2.2) |
|
$ |
4.2 |
|
|
Net income |
|
$ |
11.6 |
|
$ |
40.2 |
|
$ |
51.8 |
|
|
Diluted earnings per share |
|
$ |
0.13 |
|
$ |
0.45 |
|
$ |
0.58 |
|
